Abstract
Objectives: Most patients diagnosed with advanced epithelial ovarian carcinoma (EOC) relapse with resistant disease, and there are no clinically useful biomarkers to identify or monitor this resistance. This study sought to identify differential secreted proteins collected from human EOC cell lines of varying platinum sensitivity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have